Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow-to-Debt Ratio
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. cash flow-to-debt ratio. Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow-to-Debt Ratio of 0.28x as of September 2024, meaning its operating cash flow of TL33.37 Million could theoretically repay 0% of its total liabilities (TL120.48 Million) in one year. Check Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
Cash flow-to-debt ratio of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023. Historical debt coverage capacity for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 4 annual periods. Check Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow-to-Debt Ratio by Year (2020–2023)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. cash flow-to-debt ratio by year from 2020 to 2023. Year-by-year debt coverage analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For the full cash flow conversion analysis, see Oncosem Onkolojik Sistemler Sanayi ve Ti cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.36x | TL-38.10 Million | TL106.61 Million | ▼ -185.1% |
| 2022 | 0.42x | TL52.69 Million | TL125.50 Million | ▼ -58.8% |
| 2021 | 1.02x | TL51.68 Million | TL50.75 Million | ▲ +194.4% |
| 2020 | 0.35x | TL19.41 Million | TL56.11 Million | — |